Case Updates
Second Circuit affirms district court decision rejecting constitutional challenges to drug-price-control provisions of Inflation Reduction Act, holding that manufacturers’ participation in the IRA program is voluntary
August 07, 2025
U.S. Chamber files amicus brief urging Second Circuit to reverse district court decision rejecting constitutional challenges to drug-price-control provisions of Inflation Reduction Act
November 12, 2024
As the brief explains, the price-control program is coercive, not voluntary, and a decision upholding the program would undermine private-sector innovation, investment, and public-private partnerships.
Kwaku A. Akowuah and Brenna E. Jenny of Sidley Austin LLP served as outside counsel.